✦ LIBER ✦

Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis

✍ Scribed by Andrew Briggs; Mark Sculpher; Martin Buxton

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 945 KB
Volume: 3
Category: Article
ISSN: 1057-9230
DOI: 10.1002/hec.4730030206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discounting and decision making in the e

Discounting and decision making in the economic evaluation of health-care technologies

✍ Karl Claxton; Mike Paulden; Hugh Gravelle; Werner Brouwer; Anthony J. Culyer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

Discounting costs and health benefits in cost-effectiveness analysis has been the subject of recent debate -some authors suggesting a common rate for both and others suggesting a lower rate for health. We show how these views turn on key judgments of fact and value: on whether the social objective i

‘Health Economics’ and the evolution of

‘Health Economics’ and the evolution of economic evaluation of health technologies

✍ John Hutton 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

Economic evaluation and the postponement

Economic evaluation and the postponement of health care costs

✍ Pieter H. M. van Baal; Talitha L. Feenstra; Johan J. Polder; Rudolf T. Hoogenvee 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

The inclusion of medical costs in life years gained in economic evaluations of health care technologies has long been controversial. Arguments in favour of the inclusion of such costs are gaining support, which shifts the question from whether to how to include these costs. This paper elaborates on

Estimating production costs in the econo

Estimating production costs in the economic evaluation of health-care programs

✍ Carmen Herrero; Juan D. Moreno-Ternero 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 3 views

## Abstract We propose a method for calculating the production costs of an intervention in a manner that accounts for differences in productive ‘effort.’ This method could be used within a cost‐effectiveness analysis framework in the evaluation of new medical technologies, pharmaceuticals, treatmen

The increasing role of health economic e

The increasing role of health economic evaluations in drug development

✍ Lieven Annemans; Irina Cleemput; Steven Simoens; Francis Arickx; Frank Hulstaert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

Health care economics of cancer in the e

Health care economics of cancer in the elderly

✍ Joseph S. Bailes 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

Changing economic circumstances have brought increased pressure to bear on the traditional revenue sources of oncologists. Practice standards and settings are being challenged to generate cost savings both for third-party payers and for oncology practices. Add to this the growing number of patients